Dapagliflozin significantly reduced liver fat accumulation associated with a decrease in abdominal subcutaneous fat in patients with inadequately controlled type 2 diabetes mellitus
{{output}}
Aims: We examined dapagliflozin-induced changes in liver fat accumulation. Methods: We prospectively recruited Japanese patients with inadequat... ...
